Ventyx Biosciences, Inc.
VTYX
$7.94
-$1.44-15.35%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | 15.41% | 1.65% | 6.51% | 16.73% | -10.33% |
| Total Depreciation and Amortization | 0.93% | -9.27% | 13.02% | 1.94% | -2.22% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 8.46% | -5.09% | 11.19% | 8.84% | -6.08% |
| Change in Net Operating Assets | -31.44% | 202.61% | -176.82% | 180.21% | -182.54% |
| Cash from Operations | 17.71% | 17.27% | -10.62% | 34.44% | -44.51% |
| Capital Expenditure | -19.05% | -162.50% | -166.67% | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -32.23% | -4.53% | 340.46% | -137.58% | 138.76% |
| Cash from Investing | -32.32% | -4.63% | 340.18% | -137.60% | 138.73% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 198.53% | -- | -- | 1,750.00% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 198.53% | -- | -- | -100.09% | 3,064.90% |
| Foreign Exchange rate Adjustments | -131.82% | 103.36% | 151.07% | -221.35% | 2,233.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -107.83% | 417.77% | 102.36% | -265.57% | 120.64% |